Back to Search Start Over

Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.

Authors :
Groen JV
Michiels N
van Roessel S
Besselink MG
Bosscha K
Busch OR
van Dam R
van Eijck CHJ
Koerkamp BG
van der Harst E
de Hingh IH
Karsten TM
Lips DJ
de Meijer VE
Molenaar IQ
Nieuwenhuijs VB
Roos D
van Santvoort HC
Wijsman JH
Wit F
Zonderhuis BM
de Vos-Geelen J
Wasser MN
Bonsing BA
Stommel MWJ
Mieog JSD
Source :
The British journal of surgery [Br J Surg] 2021 Dec 17; Vol. 109 (1), pp. 96-104.
Publication Year :
2021

Abstract

Background: Venous resection of the superior mesenteric or portal vein is increasingly performed in pancreatic cancer surgery, whereas results of studies on short- and long-term outcomes are contradictory. The aim of this study was to evaluate the impact of the type of venous resection in pancreatoduodenectomy for pancreatic cancer on postoperative morbidity and overall survival.<br />Methods: This nationwide retrospective cohort study included all patients who underwent pancreatoduodenectomy for pancreatic cancer in 18 centres (2013-2017).<br />Results: A total of 1311 patients were included, of whom 17 per cent underwent wedge resection and 10 per cent segmental resection. Patients with segmental resection had higher rates of major morbidity (39 versus 20 versus 23 per cent, respectively; P < 0.001) and portal or superior mesenteric vein thrombosis (18 versus 5 versus 1 per cent, respectively; P < 0.001) and worse overall survival (median 12 versus 16 versus 20 months, respectively; P < 0.001), compared to patients with wedge resection and those without venous resection. Multivariable analysis showed patients with segmental resection, but not those who had wedge resection, had higher rates of major morbidity (odds ratio = 1.93, 95 per cent c.i. 1.20 to 3.11) and worse overall survival (hazard ratio = 1.40, 95 per cent c.i. 1.10 to 1.78), compared to patients without venous resection. Among patients who received neoadjuvant therapy, there was no difference in overall survival among patients with segmental and wedge resection and those without venous resection (median 32 versus 25 versus 33 months, respectively; P = 0.470), although there was a difference in major morbidity rates (52 versus 19 versus 21 per cent, respectively; P  = 0.012).<br />Conclusion: In pancreatic surgery, the short- and long-term outcomes are worse in patients with venous segmental resection, compared to patients with wedge resection and those without venous resection.<br /> (© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd.)

Details

Language :
English
ISSN :
1365-2168
Volume :
109
Issue :
1
Database :
MEDLINE
Journal :
The British journal of surgery
Publication Type :
Academic Journal
Accession number :
34791069
Full Text :
https://doi.org/10.1093/bjs/znab345